For citations:
Kurenkov A.L., Kuzenkova L.M., Uvakina E.V., Chernikov V.V., Popovich S.G., Fisenko D.A., Bursagova B.I., Globa O.V., Andreenko N.V., Abdullaeva L.M., Kurova J.A., Adalimova N.S., Nikolenko D.S., Lyalina A.A., Myagkiy F.V. Results of a Two-Year Comprehensive Follow-Up of Patients with Spinal Muscular Atrophy Type I Who Received Gene Therapy with Onasemnogen Abeparvovek. L.O. Badalyan Neurological Journal. 2026;7(2):74-87. (In Russ.) https://doi.org/10.46563/2686-8997-2026-7-1-230
JATS XML
Email this article 
